SINT Sintx Technologies, Inc.
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1269026 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY160.8%
TTM net income YoY5.2%
TTM EPS YoY13.0%
Revenue 3-yr CAGR10.0%
Net income 3-yr CAGR—
Margins
Gross margin59.5%
Operating margin-303.4%
Net margin-281.9%
FCF margin-279.2%
EBITDA margin-295.3%
Returns
ROE-250.4%
ROA-92.1%
ROIC (approx.)—
Asset turnover0.33x
Leverage & solvency
Liabilities / assets61.9%
Debt / equity0.00x
Current ratio1.84x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.96x
Accruals ratio-3.6%
Payout ratio—
Capex / revenue8.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $2.19M | $452,000 | $380,000 | $290,000 | $208,000 | $151,000 | $369,000 | $542,000 |
| Cost of revenue | $828,000 | $174,000 | $236,000 | $102,000 | $115,000 | $94,000 | $246,000 | $154,000 |
| Gross profit | $1.36M | $278,000 | $144,000 | $188,000 | $93,000 | $57,000 | $123,000 | $388,000 |
| R&D expense | $548,000 | $573,000 | $364,000 | $969,000 | $1.26M | $1.24M | $1.12M | $709,000 |
| SG&A expense | $2.25M | $2.32M | $2.54M | $1.36M | $2.10M | $1.42M | $1.32M | $1.00M |
| Operating income | -$1.64M | -$2.89M | -$3.21M | -$2.32M | -$3.35M | -$2.67M | -$2.38M | -$1.73M |
| Pretax income | -$1.59M | -$2.71M | -$2.82M | -$2.21M | -$3.54M | -$2.32M | -$2.29M | -$1.70M |
| Net income | -$1.59M | -$2.71M | -$2.82M | -$2.21M | -$3.54M | -$2.32M | -$2.29M | -$1.70M |
| EBITDA | -$1.57M | -$2.82M | -$3.14M | -$2.24M | -$3.28M | -$2.59M | -$2.29M | -$1.62M |
| EPS (basic) | -0.24 | -0.75 | -0.70 | — | -3.46 | -0.91 | -1.29 | — |
| EPS (diluted) | -0.24 | -0.75 | -0.70 | — | -3.46 | -0.91 | -1.29 | — |
| Weighted avg. shares (diluted) | 6.67M | 4.85M | 4.01M | — | 2.96M | 2.54M | 1.77M | — |
| Banking | ||||||||
| Deposits | — | — | — | — | $1.80M | $750,000 | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $2.00M | $3.59M | $1.89M | $4.14M | $6.25M | $4.32M | $6.50M | $3.60M |
| Inventory | $2.56M | $2.25M | $1.39M | $825,000 | $447,000 | $355,000 | $425,000 | $502,000 |
| Current assets | $5.52M | $7.03M | $4.32M | $5.65M | $7.39M | $5.55M | $7.62M | $4.52M |
| PP&E, net | $518,000 | $434,000 | $415,000 | $476,000 | $507,000 | $499,000 | $575,000 | $922,000 |
| Goodwill | $302,000 | $302,000 | $302,000 | $302,000 | $302,000 | — | — | — |
| Intangibles | $116,000 | $125,000 | $133,000 | $142,000 | $150,000 | $14,000 | $15,000 | $16,000 |
| Total assets | $8.90M | $10.43M | $7.81M | $9.51M | $11.36M | $9.20M | $11.45M | $9.41M |
| Current liabilities | $3.00M | $2.98M | $4.17M | $3.73M | $4.35M | $2.16M | $2.21M | $1.98M |
| Short-term debt | $55,000 | $102,000 | $106,000 | $7,000 | $59,000 | $109,000 | $131,000 | $32,000 |
| Total liabilities | $5.51M | $5.60M | $6.91M | $6.58M | $7.30M | $5.21M | $5.36M | $5.52M |
| Shareholders' equity | $3.39M | $4.83M | $904,000 | $2.93M | $4.07M | $3.99M | $6.09M | $3.89M |
| Shares outstanding | 6.89M | 6.61M | 4.12M | 3.97M | 3.62M | 2.49M | 2.49M | 1.34M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.37M | -$2.77M | -$2.49M | -$2.34M | -$2.52M | -$2.41M | -$1.30M | -$1.12M |
| Capital expenditure | $144,000 | $84,000 | $7,000 | $42,000 | $84,000 | $0 | $59,000 | $146,000 |
| Free cash flow | -$1.51M | -$2.85M | -$2.50M | -$2.39M | -$2.60M | -$2.41M | -$1.36M | -$1.27M |
| Investing cash flow | -$144,000 | -$84,000 | -$7,000 | -$42,000 | $666,000 | $352,000 | -$63,000 | $10,000 |
| Financing cash flow | -$72,000 | $4.55M | $247,000 | $276,000 | $3.78M | -$123,000 | $4.27M | -$102,000 |
| Depreciation & amortization | $61,000 | $64,000 | $68,000 | $74,000 | $74,000 | $76,000 | $95,000 | $115,000 |
| Stock-based compensation | $275,000 | $317,000 | $530,000 | $651,000 | $546,000 | $175,000 | $18,000 | $7,000 |
| Share buybacks | — | — | — | $0 | $0 | $47,000 | $86,000 | — |
Free plan shows the latest 8 periods; Pro shows all 55 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.